ORALBUTE ORAL PASTE ANTI-INFLAMMATORY ANALGESIC FOR HORSES

Country: Australia

Language: English

Source: APVMA (Australian Pesticides and Veterinary Medicines Authority)

Buy It Now

Active ingredient:

PHENYLBUTAZONE

Available from:

ABBEY LABORATORIES PTY LTD

INN (International Name):

phenylbutazone(200mg/mL)

Pharmaceutical form:

ORAL PASTE

Composition:

PHENYLBUTAZONE ANALGESIC Active 200.0 mg/ml

Units in package:

1 x 20 mL syringe; 1 x 60 mL syringe; 10 X 60 mL syringes; 5 x 20 mL syringes; 5 x 60 mL syringes; 50 X 60 mL syringes

Class:

VM - Veterinary Medicine

Therapeutic group:

HORSE | COLT | DONKEY | ENDURANCE HORSE | FILLY | FOAL | GELDING | HIGH PERFORMANCE HORSES | HORSES AT STUD | MARE | PACER | POL

Therapeutic area:

MUSCULOSKELETAL SYSTEM

Therapeutic indications:

ANALGESIC | ANTI-INFLAMMATORY AGENT | ANTIPYRETIC | BONE SORENESS | BRUISING | BURSITIS | COLIC | INFLAMMATORY RHEUMATIC ARTHRIT | JOINT DISEASE | LIGAMENT SPRAINS | MUSCLE RELAXANT | MUSCLE SORENESS | OSTEOARTHRITIS | PLATELET ACTIVITY | RHEUMATISM | SEDATIVE | SPASMOLYTIC | SPRAINS | STRAINS | TENDON SPRAINS | TRAUMATIC SWELLING

Product summary:

Poison schedule: 4; Withholding period: DO NOT USE in horses that may be used fo r human consumption.; Host/pest details: HORSE: [ANALGESIC, ANTI-INFLAMMATORY AGENT]; Poison schedule: 4; Withholding period: WHP: MEAT - DO NOT USE LESS THAN 28 DAY S BEFORE SLAUGHTER FOR HUMAN CONSUMPTIO N.; Host/pest details: HORSE: [ANALGESIC, ANTI-INFLAMMATORY AGENT]; Poison schedule: 4; Withholding period: ; Host/pest details: HORSE: [ANALGESIC, ANTI-INFLAMMATORY AGENT]; Indicated for the control of inflammation in horses following acute strains of joints, tendons and ligaments. It is a treatment in serous arthritis and other musculoskeletal conditions and in conjunction with antibiotics, in infectious arthritis.Do not use in horses where sever cardiac, renal or hepatic dysfunction, gastrointestinal tract ulceration or blood dystrasia is suspected.

Authorization status:

Registered

Authorization date:

2023-07-01

Patient Information leaflet

                                PRESCRIPTION ANIMAL REMEDY
KEEP
QUT
OF REACH OF CHILDREN
FOR
ANIMAL
TREATMENT ONLY
ORALBUTE
O&U,
PASTE
*
ANTI
-
INFLAMMATORY ANALGESIC FOR HORSES
Active Constituent: PHENYLBUTAZONE
2OOmg/mL
CONTENTS: 5 x
2011~
READ THE ENCLOSED LEAFLET BEFORE USING THIS PRODUCT
DIRECTIONS FOR USE:
Remove cap from nozzle of syringe. Direct the nozzle of the syringe
into the side
of the horse’s empty mouth. Depress the plunger to dispense the
desired dose onto the tongue.
Keep
mouth
closed for a few seconds to ensure that the dose is swallowed. Replace
cap after use.
DOSAGE:
Horses
-
4.4mg/kg
(lOnW450kg)
twice on day 1, then
2.2mg/kg
(5mL/450kg)
twice daily for 4
.
days, then
2.2mg/kg
(5mL1450kg)
daily or alternate days as required.
L
PONIES
-
2.2mg/kg:
(2.5mL1225kg)
twice on day 1, then
2.2mg/kg
(2.5mL/225kg)
daily for 4 days or as
directed by the veterinarian. It is advisable to give food immediately
after administration of the dose.
MEAT WITHHOLDING PERIOD: DO NOT USE LESS THAN 28 DAYS BEFORE SLAUGHTER
FOR HUMAN CONSUMPTION.
DISPOSE OF EMPTY CONTAINERS BY WRAPPING IN PAPER AND PUTTING IN
GARBAGE.
E QUIVE T
PTY
LT,
Store
Below
25oC
(Air
Conditioning)
‘NR;;;;;;
323
EAST KURRAJONG RD
EAST KURRAJONG NSW 2758
EXPIRY:
AUSTRALIA
TEL: (045) 77 4353
BATCH:
PRESCRIPTION ANIMAL REMEDY
KEEP
OUT
OF REACH OF CHILDREN
FOR ANIMAL TREATMENT ONLY
ORALBUTE
* ORAL PASTE
ANTI
- INFLAMMATORY ANALGESIC FOR HORSES
ACTIVE CONSTITUENT
- PHENYLBUTAZONE 200
MG/ML
ORALBUTE oral paste is an anti-inflammatory analgesic for use
In
horses. The active Ingredient is phenylbutazone at a concentration of
1 g in
each
5mL
of paste. Oralbute is indicated
for the control of inflammation
in horses following acute strains of joints, tendons and ligaments. It
is a
palliative treatment in serous arthritis and, in conjunction with
antibiotics, in infectious arthritis. It is useful in the relief of
pain and inflammation
following surgical procedures, wounds and contusions, bursitis, common
lameness, osteoarthritis, disc syndromes and rheumatism.
ORALBUTE is presented as 
                                
                                Read the complete document